Department of Paediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
Center for Rare Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Clin Endocrinol (Oxf). 2024 Aug;101(2):121-129. doi: 10.1111/cen.15105. Epub 2024 Jun 21.
Structured transition of adolescents and young adults with a chronic endocrine disease from paediatric to adult care is important. Until now, no data on time and resources required for the necessary components of the transition process and the associated costs are available.
DESIGN, PATIENTS AND MEASUREMENTS: In a prospective cohort study of 147 patients with chronic endocrinopathies, for the key elements of a structured transition pathway including (i) assessment of patients' disease-related knowledge and needs, (ii) required education and counselling sessions, (iii) compiling an epicrisis and a transfer appointment of the patient together with the current paediatric and the future adult endocrinologist resource consumption and costs were determined.
One hundred and forty-three of 147 enroled patients (97.3%) completed the transition pathway and were transferred to adult care. The mean time from the decision to start the transition process to the final transfer consultation was 399 ± 159 days. Transfer consultations were performed in 143 patients, including 128 patients jointly with the future adult endocrinologist. Most consultations were performed by a multidisciplinary team consisting of a paediatric and adult endocrinologist, psychologist, nurse, and a social worker acting also as a case manager with a median of three team members and lasted 87.6 ± 23.7 min. The mean cumulative costs per patient of all key elements were 519 ± 206 Euros. In addition, costs for case management through the transition process were 104.8 ± 28.0 Euros.
Using chronic endocrine diseases as an example, it shows how to calculate the time and cost of a structured transition pathway from paediatric to adult care, which can serve as a starting point for sustainable funding for other chronic rare diseases.
对患有慢性内分泌疾病的青少年和年轻人进行从儿科到成人护理的结构化过渡非常重要。到目前为止,尚无关于过渡过程必要组成部分所需的时间和资源以及相关成本的数据。
设计、患者和测量方法:在一项针对 147 名患有慢性内分泌疾病患者的前瞻性队列研究中,对结构化过渡途径的关键要素进行了评估,包括:(i)评估患者的疾病相关知识和需求;(ii)所需的教育和咨询课程;(iii)编写患者的电子病历和转介预约,以及当前儿科和未来成人内分泌医生的资源消耗和成本。
147 名入组患者中有 143 名(97.3%)完成了过渡途径并转至成人护理。从决定开始过渡过程到最终转介咨询的平均时间为 399±159 天。在 143 名患者中进行了转介咨询,其中 128 名患者与未来的成人内分泌医生共同进行了咨询。大多数咨询由一个多学科团队进行,该团队由儿科和成人内分泌医生、心理学家、护士和社会工作人员组成,他们还担任病例管理员,平均有三名团队成员,持续 87.6±23.7 分钟。每位患者所有关键要素的平均累积成本为 519±206 欧元。此外,通过过渡过程进行病例管理的成本为 104.8±28.0 欧元。
以慢性内分泌疾病为例,展示了如何计算从儿科到成人护理的结构化过渡途径的时间和成本,这可以为其他慢性罕见疾病的可持续融资提供起点。